{"gene":"HS3ST1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1999,"finding":"HS3ST1 (3-OST-1) encodes a heparan sulfate D-glucosaminyl 3-O-sulfotransferase that transfers sulfate from PAPS to the 3-OH position of specific glucosamine residues within heparan sulfate, converting nonanticoagulant heparan sulfate (HSinact) to anticoagulant heparan sulfate (HSact); it is a type II integral membrane protein with a carboxyl-terminal sulfotransferase domain as the self-contained functional unit.","method":"cDNA cloning, expression in COS-7 cells, radiolabeled PAPS sulfotransferase activity assay, disaccharide analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic assay with substrate characterization, replicated across companion papers","pmids":["9988767","9988768"],"is_preprint":false},{"year":1999,"finding":"3-OST-1 exhibits distinct substrate specificity compared to other 3-OST isoforms: it is 300-fold more efficient than 3-OST-2 or 3-OST-3A at generating anticoagulant heparan sulfate binding sites for antithrombin; the sulphotransferase domain alone determines this isoform-specific sequence selectivity, as shown by domain-swap chimeras.","method":"COS-7 cell expression, PAPS sulfotransferase activity assay, HSact conversion assay, domain-swap chimera analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro activity assay with mutagenesis/domain swaps replicated in multiple studies","pmids":["9988768","11563988"],"is_preprint":false},{"year":2001,"finding":"The sulphotransferase domain of 3-OST-1 is a portable, self-contained unit that determines its sequence specificity for generating antithrombin-binding sites; swapping the sulphotransferase domain of 3-OST-1 into 3-OST-3A context (N3A-ST1 chimera) conferred 3-OST-1-like antithrombin-binding activity, while swapping the N-terminal region had no effect on specificity.","method":"Domain-swap chimeras expressed in COS-7 cells, antithrombin-binding site generation assay, CHO cell transfection with HSV-1 entry susceptibility assay","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — domain-swap mutagenesis with orthogonal functional readouts (antithrombin binding and viral entry)","pmids":["11563988"],"is_preprint":false},{"year":2001,"finding":"6-O-sulfotransferase-1 (6-OST-1) acts as a limiting enzyme upstream of 3-OST-1 in the anticoagulant heparan sulfate biosynthetic pathway; 3-OST-1 introduced into CHO cells via retroviral transduction confers HSact production, and chemical mutagenesis of these cells showed 6-OST-1 deficiency blocked HSact generation, which was rescued by 6-OST-1 transfection.","method":"Retroviral transduction of 3-OST-1 into CHO cells, chemical mutagenesis screen, in vitro 6-OST-1 modification assay, capillary HPLC-MS disaccharide analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — genetic epistasis in cell-based system with biochemical rescue, multiple orthogonal methods","pmids":["11551899"],"is_preprint":false},{"year":2002,"finding":"Recombinant human 3-OST-1 expressed in E. coli is soluble and catalytically active, with apparent Km values of 4.3 µM for heparan sulfate and 38.6 µM for PAPS, and Vmax ~18-21 pmol sulfate/min/pmol enzyme, comparable to baculovirus-expressed enzyme.","method":"E. coli recombinant expression, radiochemical sulfotransferase assay with [35S]PAPS and bovine kidney heparan sulfate","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinetic characterization of purified recombinant enzyme","pmids":["11811991"],"is_preprint":false},{"year":2002,"finding":"Structure-function analysis by homology modeling of 3-OST-1 identified specific structural motifs and amino acid residues likely critical for enzymatic function of the sulphotransferase domain.","method":"Homology modeling based on crystal structures of related enzymes, structural analysis tools","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 4 — computational prediction only, no experimental mutagenesis validation in this paper","pmids":["11811992"],"is_preprint":false},{"year":2003,"finding":"Hs3st1 knockout mice (Hs3st1-/-) lack 3-OST-1 enzyme activity in plasma and tissues and show dramatic reductions in anticoagulant heparan sulfate (HSact), yet exhibit normal hemostasis (normal fibrin accumulation, normal carotid artery occlusion times, normal thrombin-antithrombin complexes), demonstrating that bulk HSact is not essential for normal hemostasis in vivo. Unexpectedly, these mice exhibited genetic background-specific lethality and intrauterine growth retardation without coagulopathy, suggesting 3-OST-1-derived structures serve additional biological roles.","method":"Hs3st1-/- knockout mouse generation, enzyme activity assays, ferric chloride carotid artery injury model, fibrin accumulation assay under normoxia/hypoxia, thrombin-antithrombin complex measurement","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — clean KO mouse with multiple in vivo phenotypic readouts across multiple methods","pmids":["12671048"],"is_preprint":false},{"year":2000,"finding":"3-OST-1 enzymatically modifies heparan sulfate on a biochip by introducing the critical 3-O-sulfo group into the pentasaccharide sequence, converting low-affinity ATIII-binding HS to high-affinity ATIII-binding HS, as demonstrated by surface plasmon resonance.","method":"Biochip-bound heparan sulfate, enzymatic modification with 3-OST-1 and PAPS, surface plasmon resonance spectroscopy","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro enzymatic reconstitution with functional binding readout","pmids":["11006120"],"is_preprint":false},{"year":2012,"finding":"Crystal structure of the ternary complex of 3-OST-1 with 3'-phosphoadenosine 5'-phosphate and a heptasaccharide substrate was solved, revealing the substrate-binding mode and showing that Arg268 in 3-OST-1 is a key residue for substrate specificity distinguishing it from 3-OST-3; saccharide substrates display distinct conformations when interacting with different 3-OST isoforms.","method":"X-ray crystallography of ternary complex, site-directed mutagenesis of active-site residues","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mutagenesis validation, single rigorous study","pmids":["22431632"],"is_preprint":false},{"year":2013,"finding":"Golgi-targeted HS3ST1 (but not untargeted HS3ST1) localizes to the Golgi apparatus and produces antithrombin III-binding sites with high anti-factor Xa activity in CHO cells; overexpression of HS3ST1 also upregulates 2-O-, 6-O-, and N-sulfo group-containing disaccharides, indicating concerted interplay among HS biosynthetic enzymes.","method":"Subcellular targeting constructs expressed in CHO cells, flow cytometry ATIII binding assay, anti-factor Xa assay, AMAC-LCMS disaccharide analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — localization experiment directly linked to functional biosynthetic outcome with multiple orthogonal methods","pmids":["24247246"],"is_preprint":false},{"year":2017,"finding":"HS3ST1 genotype controls endothelial cell production of HSAT+ (antithrombin-binding heparan sulfate); in Hs3st1-/- mice, antithrombin lost its anti-inflammatory activity and instead exerted pro-inflammatory effects in LPS-induced septic shock, demonstrating that HSAT+ is required for AT's anti-inflammatory but not anticoagulant activity. An intronic SNP (rs16881446) in HS3ST1 associated with reduced expression in endothelial cells and with coronary artery disease severity.","method":"Hs3st1-/- knockout mouse model, LPS-induced septic shock model, leukocyte firm adhesion assay, isolated coronary arteriole dilation assay, human candidate-gene association study, endothelial cell gene expression","journal":"Matrix biology : journal of the International Society for Matrix Biology","confidence":"High","confidence_rationale":"Tier 2 — KO mouse with multiple mechanistic phenotypic readouts plus human genetic validation","pmids":["28126521"],"is_preprint":false},{"year":2016,"finding":"3-O-sulfation of heparan sulfate by Hs3st1 (but not Hs3st2) enhanced binding of neuropilin-1 to heparan sulfate; 3-O-sulfated HS dodecamers inhibited neuropilin-1-dependent semaphorin-3a-induced growth cone collapse in dorsal root ganglion neurons from wild-type but not Hs3st1-deficient mice, and inhibited endothelial cell sprouting.","method":"Affinity chromatography with 3-O-sulfated HS columns, ELISA binding assay, thermal shift assay, neuronal growth cone collapse assay using Hs3st1-/- and Hs3st2-/- mouse neurons, endothelial cell sprouting assay","journal":"ACS chemical biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal assays with genetic KO specificity controls","pmids":["26731579"],"is_preprint":false},{"year":2019,"finding":"3-O-sulfation of heparan sulfate generated by HS3ST1 significantly enhances tau binding to cell-surface heparan sulfate and tau cellular internalization; Hs3st1-/- cells showed reduced 3-O-sulfate levels, diminished cell-surface tau binding, and reduced tau internalization; NMR titrations mapped 3-O-S binding to the R2 and PRR2 regions of tau.","method":"HS microarray, surface plasmon resonance, Hs3st1-/- cell lines, tau cell-surface binding and internalization assays, NMR titration, competitive inhibition with soluble 3-O-S HS 12-mer","journal":"Angewandte Chemie (International ed. in English)","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including KO cells, SPR, NMR, and functional cellular assays","pmids":["31692167"],"is_preprint":false},{"year":2022,"finding":"3-O-sulfation of heparan sulfate produced by HS3ST1 contributes to the cellular uptake of tau aggregates; HS3ST1-/- cells showed reduced tau aggregate uptake, confirmed by LC-MS/MS quantification of 3-O-sulfated HS products; antithrombin III competition reduced tau uptake, and 3-O-sulfated HS showed higher affinity for aggregated tau.","method":"HS3ST1-/- cell lines, tau aggregate uptake assay, LC-MS/MS with 13C-labeled HS calibrants, antithrombin III competition assay","journal":"BMC molecular and cell biology","confidence":"High","confidence_rationale":"Tier 2 — KO cells with multiple orthogonal biochemical and functional assays","pmids":["36564747"],"is_preprint":false},{"year":2023,"finding":"HS3ST1-encoded 3-OST-1 produces a specific 3-O-sulfated heparan sulfate that is elevated sevenfold in Alzheimer's disease brains; this specific 3-O-sulfated HS (identified by LC-MS/MS) enhances tau internalization, and its addition as a synthetic 14-mer inhibited tau cellular uptake, implicating HS3ST1 overexpression in tau pathology spread.","method":"LC-MS/MS analysis of brain HS from AD patients and controls, recombinant sulfotransferase modification, Hs3st1 knockout mouse HS analysis, synthetic 14-mer inhibition of tau internalization","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1-2 — human tissue biochemistry, KO mouse confirmation, and functional synthetic oligosaccharide intervention","pmids":["37235665"],"is_preprint":false},{"year":2023,"finding":"All ApoE isoforms (ApoE2, ApoE3, ApoE4) recognize 3-O-sulfated heparan sulfate produced by HS3ST1; knockout of HS3ST1 in cells reduced ApoE cell-surface binding and uptake; NMR titration localized ApoE/3-O-S binding to the vicinity of the canonical HS binding motif.","method":"Glycan microarray, surface plasmon resonance, HS3ST1 knockout cells, ApoE binding and uptake assays, NMR titration","journal":"Angewandte Chemie (International ed. in English)","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods with KO cell validation and structural NMR data","pmids":["37014788"],"is_preprint":false},{"year":2020,"finding":"ZNF263, a C2H2 zinc finger transcription factor, negatively regulates HS3ST1 expression; CRISPR-mediated or siRNA knockdown of ZNF263 dramatically increased HS3ST1 expression, enhanced 3-O-sulfation, increased antithrombin binding, enhanced Factor Xa inhibition, and increased neuropilin-1 binding.","method":"CRISPR targeting and siRNA knockdown of ZNF263 in mammalian cell lines and human primary cells, qPCR, antithrombin binding assay, Factor Xa inhibition assay, neuropilin-1 binding assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — two independent knockdown approaches with multiple functional readouts","pmids":["32277030"],"is_preprint":false},{"year":2012,"finding":"Hs3st1 silencing in pancreatic beta-cell line MIN6T3 cells reduced glucose-induced insulin secretion (GIIS), implicating the 3-O-sulfate group on heparan sulfate produced by Hs3st1 in the insulin secretory pathway upstream of membrane depolarization.","method":"siRNA knockdown of Hs3st1, glucose-induced insulin secretion assay, sodium chlorate inhibition experiments, qRT-PCR","journal":"Journal of diabetes investigation","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional KD with specific cellular phenotype, single lab, single method","pmids":["24843591"],"is_preprint":false},{"year":2023,"finding":"HS3ST1 promotes NSCLC cell malignant behaviors by inhibiting SPOP expression, which normally mediates degradation of FADD, thereby activating the NF-κB pathway; HS3ST1 knockdown suppressed tumor growth in vitro and in vivo.","method":"HS3ST1 knockdown/overexpression in NSCLC cell lines, in vivo xenograft model, SPOP/FADD/NF-κB pathway analysis","journal":"BioMed research international","confidence":"Low","confidence_rationale":"Tier 3 — single lab, functional KD with pathway analysis, but paper subsequently retracted (PMID 38188779)","pmids":["35909476","38188779"],"is_preprint":false},{"year":2023,"finding":"In castration-resistant prostate cancer cells (C4-2), EGF-activated EGFR-ERK1/2 signaling under hormone-depleted conditions depends on 3-O-sulfated heparan sulfate produced by HS3ST1; HS3ST1 knockdown suppressed hormone-independent growth, inhibited EGF binding to the cell surface, and blocked EGFR-ERK1/2 activation.","method":"HS3ST1 knockdown in C4-2 cells, hormone-depletion culture conditions, EGF binding assay, EGFR-ERK1/2 phosphorylation, xenograft mouse model with gefitinib","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional KD with specific signaling pathway readout and in vivo validation, single lab","pmids":["37463954"],"is_preprint":false},{"year":2025,"finding":"HS3ST1 is required for antithrombin-binding heparan sulfate (HSAT) expression in epithelial basement membranes; inactivation of HS3ST1 in pancreatic ductal adenocarcinoma cells eliminated HSAT, induced an inflammatory phenotype, suppressed apoptosis markers, and increased metastasis in experimental mouse models; HSAT-positive cells bind antithrombin, which inhibits tissue factor/factor VIIa-dependent thrombin generation.","method":"HS3ST1 inactivation in PDAC cells, immunostaining, mouse PDAC metastasis model, AT binding assay, thrombin generation assay, plasma HSAT measurement from PDAC patients","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — genetic inactivation in cells and in vivo model with multiple mechanistic readouts","pmids":["40924474"],"is_preprint":false},{"year":2019,"finding":"HS3ST1 overexpression in renal epithelial cells (HKC8-HS3ST1) prolonged STAT3 phosphorylation in response to HB-EGF compared to a transient response in control cells, indicating that HS 3-O-sulfation produced by HS3ST1 modulates HB-EGF signaling in renal epithelial cells.","method":"HS3ST1 overexpression in HKC8 cells, HB-EGF stimulation, STAT3 phosphorylation time-course assay","journal":"Biochimica et biophysica acta. General subjects","confidence":"Medium","confidence_rationale":"Tier 3 — overexpression with specific signaling readout, single lab","pmids":["30794825"],"is_preprint":false},{"year":2026,"finding":"The 3-OST-1 E86Q mutant acts as a dominant-negative inhibitor: it retains substrate and PAPS donor binding but abolishes catalytic activity, reducing wild-type 3-OST-1-like activity by >80% in vitro and significantly decreasing 3-O-sulfated HS products in cells without affecting overall HS abundance, identifying E86 as critical for catalysis.","method":"E86Q site-directed mutagenesis, LC-MS/MS enzymatic activity assay with 13C-labeled internal standards, cell-based 3-O-sulfated HS quantification","journal":"Glycobiology","confidence":"High","confidence_rationale":"Tier 1 — active-site mutagenesis with quantitative in vitro and cell-based validation","pmids":["41914643"],"is_preprint":false},{"year":2005,"finding":"In glomerular epithelial cells expressing both 3-OST-1 and 3-OST-3A, anticoagulant heparan sulfate production is regulated by an extremely limiting precursor pool rather than by limiting 3-OST-1 levels alone; Hs3st1-/- kidney sections showed continued HSPG synthesis by non-3-OST-1 isoforms in vivo, demonstrating cell-type-specific regulatory mechanisms.","method":"Radiolabeled antithrombin probing of kidney cryosections, cultured glomerular epithelial cell HS structural analysis, Hs3st1-/- mouse kidney section probing, disaccharide and transcript analyses","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical and genetic approaches in a single study","pmids":["16107334"],"is_preprint":false},{"year":2010,"finding":"Hs3st1-/- mice exhibit a strong proinflammatory phenotype that is unresponsive to antithrombin's anti-inflammatory activity, establishing that the predominant function of HSAT+ (produced by HS3ST1) is to mediate antithrombin's anti-inflammatory rather than anticoagulant activity.","method":"Hs3st1-/- knockout mouse, inflammatory model, antithrombin treatment experiments","journal":"Progress in molecular biology and translational science","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with functional phenotype, review paper summarizing primary data from previous studies","pmids":["20807645"],"is_preprint":false},{"year":2020,"finding":"siRNA knockdown of HS3ST1 (3-O-sulfotransferase 1) in endothelial cells downregulated the pro-inflammatory function of Plasmodium falciparum HRPII, supporting the hypothesis that HRPII competitively inhibits the interaction of antithrombin with 3-O-sulfate-containing vascular glycosaminoglycans produced by HS3ST1.","method":"siRNA knockdown of 3-OST-1 in endothelial cells, barrier permeability assay, AT-HRPII competition assay","journal":"Journal of thrombosis and haemostasis : JTH","confidence":"Medium","confidence_rationale":"Tier 3 — single KD experiment with functional readout, single lab","pmids":["31858717"],"is_preprint":false},{"year":2024,"finding":"HS3ST1 interacts with GPC4 (glypican-4) as shown by immunoprecipitation, and HS3ST1-mediated glycolysis is promoted by GPC4; hypoxia-derived exosomal lncRNA OIP5-AS1 enhances this HS3ST1-GPC4-mediated glycolysis via miR-200c-3p in lung adenocarcinoma cells.","method":"Co-immunoprecipitation of HS3ST1 and GPC4, cell viability, colony formation, xenograft animal models","journal":"Cancers","confidence":"Low","confidence_rationale":"Tier 3 — single Co-IP with limited mechanistic follow-up on HS3ST1 specifically","pmids":["38398086"],"is_preprint":false}],"current_model":"HS3ST1 encodes heparan sulfate D-glucosaminyl 3-O-sulfotransferase-1 (3-OST-1), a Golgi-localized type II membrane enzyme that catalyzes the rate-limiting transfer of sulfate from PAPS to the 3-OH of specific glucosamine residues in heparan sulfate chains, generating the rare 3-O-sulfated pentasaccharide motif required for high-affinity antithrombin binding (anticoagulant heparan sulfate/HSAT+); structurally, the self-contained sulphotransferase domain (with catalytic residue E86 and specificity-determining residue R268) determines isoform-specific substrate selectivity; while dispensable for normal hemostasis in vivo, HSAT+ is essential for antithrombin's anti-inflammatory activity; 3-O-sulfated HS also mediates tau and ApoE binding and cellular uptake relevant to Alzheimer's disease spread, modulates neuropilin-1/semaphorin signaling, HB-EGF/STAT3 signaling, and EGFR-ERK1/2 signaling in cancer, and its expression is negatively regulated by the transcription factor ZNF263."},"narrative":{"teleology":[{"year":1999,"claim":"Identifying HS3ST1 as the enzyme responsible for the rate-limiting 3-O-sulfation step that converts inactive heparan sulfate to antithrombin-binding anticoagulant heparan sulfate established the molecular basis for a long-known but enzymatically uncharacterized biosynthetic modification.","evidence":"cDNA cloning with recombinant expression in COS-7 cells, radiolabeled PAPS sulfotransferase assays, and disaccharide analysis","pmids":["9988767","9988768"],"confidence":"High","gaps":["No structural information on the enzyme or its substrate-binding mode","In vivo relevance of the anticoagulant HS product not yet tested"]},{"year":2001,"claim":"Domain-swap chimeras demonstrated that the C-terminal sulfotransferase domain alone dictates 3-OST-1's unique 300-fold preference for generating antithrombin-binding sites over other 3-OST isoforms, resolving how isoform specificity is encoded.","evidence":"Domain-swap chimeras between 3-OST-1 and 3-OST-3A expressed in COS-7 and CHO cells with antithrombin-binding and HSV-1 entry readouts","pmids":["11563988","9988768"],"confidence":"High","gaps":["Specific residues responsible for substrate discrimination not yet identified","Upstream biosynthetic requirements not fully defined"]},{"year":2001,"claim":"Genetic epistasis in CHO cells revealed that 6-O-sulfotransferase-1 acts upstream of 3-OST-1 in the anticoagulant HS pathway, establishing the ordered biosynthetic logic.","evidence":"Chemical mutagenesis screen in 3-OST-1-transduced CHO cells with 6-OST-1 rescue and LC-MS disaccharide analysis","pmids":["11551899"],"confidence":"High","gaps":["Whether other 6-OST isoforms can substitute remains untested","Full combinatorial sulfation code for the antithrombin-binding pentasaccharide not delineated"]},{"year":2003,"claim":"Hs3st1 knockout mice resolved a central paradox: despite dramatic loss of anticoagulant HS, hemostasis was normal, demonstrating that bulk HSAT is dispensable for coagulation homeostasis and pointing to non-anticoagulant functions.","evidence":"Hs3st1−/− mice assessed by ferric chloride carotid injury, fibrin accumulation, thrombin-antithrombin complex measurements","pmids":["12671048"],"confidence":"High","gaps":["Cause of background-specific lethality and growth retardation unexplained","Alternative in vivo roles of HSAT not yet explored"]},{"year":2012,"claim":"The crystal structure of the 3-OST-1 ternary complex with PAP and a heptasaccharide substrate identified Arg268 as the key specificity-determining residue, providing an atomic-level explanation for isoform-specific substrate recognition.","evidence":"X-ray crystallography of the ternary complex with site-directed mutagenesis validation","pmids":["22431632"],"confidence":"High","gaps":["No full-length structure including the transmembrane and stem regions","How Golgi membrane context influences activity is unknown"]},{"year":2013,"claim":"Golgi-targeted 3-OST-1 produced functional antithrombin-binding sites while also upregulating other sulfation marks, revealing that 3-O-sulfation is integrated with coordinated HS biosynthetic regulation in the Golgi.","evidence":"Subcellular targeting constructs in CHO cells with flow cytometry, anti-factor Xa assay, and AMAC-LCMS disaccharide analysis","pmids":["24247246"],"confidence":"High","gaps":["Mechanism of cross-regulation among HS biosynthetic enzymes not elucidated"]},{"year":2016,"claim":"Discovery that 3-O-sulfated HS produced by Hs3st1 enhances neuropilin-1 binding and modulates semaphorin-3a-induced growth cone collapse in neurons established a new non-anticoagulant signaling role for the 3-O-sulfate modification.","evidence":"Affinity chromatography, binding assays, neuronal growth cone collapse assays using Hs3st1−/− and Hs3st2−/− mouse neurons, endothelial sprouting assay","pmids":["26731579"],"confidence":"High","gaps":["In vivo neuronal phenotype in Hs3st1−/− mice not systematically characterized","Whether 3-O-sulfation alters semaphorin-neuropilin complex structure is unknown"]},{"year":2017,"claim":"Hs3st1 knockout mice lost antithrombin's anti-inflammatory activity during septic shock while retaining normal coagulation, definitively reassigning the primary in vivo function of HSAT from anticoagulation to anti-inflammation.","evidence":"LPS-induced septic shock in Hs3st1−/− mice with leukocyte adhesion, coronary arteriole dilation assays, and human SNP association study","pmids":["28126521"],"confidence":"High","gaps":["Mechanism by which HSAT-bound antithrombin suppresses inflammation at the molecular level not defined","Whether the rs16881446 SNP is causal or a marker remains unresolved"]},{"year":2019,"claim":"3-O-sulfated HS produced by HS3ST1 was shown to enhance tau protein binding and cellular internalization, opening an entirely new disease-relevant axis for this modification in Alzheimer's pathology.","evidence":"HS microarray, SPR, Hs3st1−/− cell tau binding and uptake assays, NMR titration mapping tau-binding epitope","pmids":["31692167"],"confidence":"High","gaps":["In vivo contribution to tau spread in brain not yet demonstrated","Receptor or co-receptor mediating 3-O-S-dependent tau internalization not identified"]},{"year":2020,"claim":"Identification of ZNF263 as a transcriptional repressor of HS3ST1 revealed an upstream regulatory mechanism controlling the abundance of 3-O-sulfated HS, with functional consequences for antithrombin binding and neuropilin-1 interaction.","evidence":"CRISPR knockout and siRNA knockdown of ZNF263 in cell lines and primary cells with qPCR, antithrombin binding, factor Xa inhibition, and neuropilin-1 binding assays","pmids":["32277030"],"confidence":"High","gaps":["Direct ZNF263 binding site on the HS3ST1 promoter not mapped","Whether ZNF263 regulation is tissue-specific in vivo is unknown"]},{"year":2023,"claim":"3-O-sulfated HS was found to be elevated sevenfold in Alzheimer's disease brains compared to controls, and all ApoE isoforms recognized this modification, linking HS3ST1 activity to two major AD risk pathways (tau and ApoE).","evidence":"LC-MS/MS of AD and control brain HS, synthetic 14-mer tau uptake inhibition, glycan microarray and SPR for ApoE binding, HS3ST1 KO cell validation","pmids":["37235665","37014788"],"confidence":"High","gaps":["Whether HS3ST1 upregulation is a cause or consequence of AD pathology is unknown","Therapeutic potential of 3-O-sulfated HS mimetics for blocking tau/ApoE binding untested in vivo"]},{"year":2025,"claim":"HS3ST1 inactivation in pancreatic cancer cells eliminated HSAT from basement membranes and increased metastasis, establishing that loss of 3-O-sulfated HS removes an antithrombin-dependent anti-metastatic barrier.","evidence":"HS3ST1 inactivation in PDAC cells, mouse metastasis model, antithrombin binding and thrombin generation assays, patient plasma HSAT measurement","pmids":["40924474"],"confidence":"High","gaps":["Whether HSAT loss is a general feature of epithelial cancers beyond PDAC is unknown","Mechanism linking HSAT loss to inflammatory phenotype in tumor cells not defined"]},{"year":2026,"claim":"Identification of E86 as the catalytic residue via dominant-negative E86Q mutagenesis provided the first active-site mechanism for 3-OST-1, complementing the structural understanding from the Arg268 specificity determinant.","evidence":"E86Q site-directed mutagenesis with LC-MS/MS enzymatic activity quantification and cell-based 3-O-sulfated HS measurement","pmids":["41914643"],"confidence":"High","gaps":["Full catalytic mechanism (acid-base vs. direct transfer) not defined","Whether E86Q dominant-negative approach works in vivo for functional studies not tested"]},{"year":null,"claim":"Major open questions include the structural basis for how 3-O-sulfated HS engages tau and ApoE at the cell surface, the identity of the internalization receptor/co-receptor for 3-O-S-dependent cargo uptake, whether HS3ST1 upregulation drives or follows AD pathology in vivo, and the full catalytic mechanism of 3-OST-1.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of 3-O-sulfated HS in complex with tau or ApoE receptor","Internalization receptor for 3-O-S-dependent tau/ApoE uptake not identified","Causal role of HS3ST1 in AD progression not demonstrated in vivo"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,4,8,22]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[9]}],"pathway":[],"complexes":[],"partners":["ANTITHROMBIN","NRP1","ZNF263","TAU","APOE","HS6ST1"],"other_free_text":[]},"mechanistic_narrative":"HS3ST1 encodes heparan sulfate D-glucosaminyl 3-O-sulfotransferase-1 (3-OST-1), a Golgi-localized type II membrane enzyme that catalyzes the transfer of sulfate from PAPS to the 3-OH position of specific glucosamine residues in heparan sulfate, generating the rare 3-O-sulfated pentasaccharide motif required for high-affinity antithrombin binding [PMID:9988767, PMID:9988768]. The sulfotransferase domain is the self-contained unit determining isoform-specific substrate selectivity, with Arg268 governing substrate discrimination and Glu86 essential for catalysis, as established by crystal structure analysis and mutagenesis [PMID:22431632, PMID:41914643, PMID:11563988]. Although Hs3st1 knockout mice lack anticoagulant heparan sulfate yet maintain normal hemostasis, they lose antithrombin's anti-inflammatory activity and exhibit a proinflammatory phenotype, while HS3ST1-generated 3-O-sulfated heparan sulfate also mediates tau and ApoE cellular uptake relevant to Alzheimer's disease, modulates neuropilin-1/semaphorin signaling, and regulates EGFR and HB-EGF signaling in cancer contexts [PMID:12671048, PMID:28126521, PMID:31692167, PMID:37014788, PMID:26731579, PMID:37463954]. HS3ST1 expression is negatively regulated by the transcription factor ZNF263, and its 3-O-sulfated products are elevated sevenfold in Alzheimer's disease brains, where they promote pathological tau spread [PMID:32277030, PMID:37235665]."},"prefetch_data":{"uniprot":{"accession":"O14792","full_name":"Heparan sulfate glucosamine 3-O-sulfotransferase 1","aliases":["Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1","3-OST-1","Heparan sulfate 3-O-sulfotransferase 1","h3-OST-1"],"length_aa":307,"mass_kda":35.8,"function":"Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) to catalyze the transfer of a sulfo group to position 3 of glucosamine residues in heparan (PubMed:8900198, PubMed:9346953, PubMed:9988768). Catalyzes the rate limiting step in the biosynthesis of heparan sulfate (HSact) (PubMed:8900198, PubMed:9988768). This modification is a crucial step in the biosynthesis of anticoagulant heparan sulfate as it completes the structure of the antithrombin pentasaccharide binding site (PubMed:8900198, PubMed:9988768)","subcellular_location":"Golgi apparatus lumen","url":"https://www.uniprot.org/uniprotkb/O14792/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HS3ST1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HS3ST1","total_profiled":1310},"omim":[{"mim_id":"609407","title":"HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 5; HS3ST5","url":"https://www.omim.org/entry/609407"},{"mim_id":"604056","title":"HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 2; HS3ST2","url":"https://www.omim.org/entry/604056"},{"mim_id":"603244","title":"HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 1; HS3ST1","url":"https://www.omim.org/entry/603244"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"ovary","ntpm":29.3}],"url":"https://www.proteinatlas.org/search/HS3ST1"},"hgnc":{"alias_symbol":["3OST1"],"prev_symbol":[]},"alphafold":{"accession":"O14792","domains":[{"cath_id":"3.40.50.300","chopping":"51-301","consensus_level":"medium","plddt":97.6081,"start":51,"end":301}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O14792","model_url":"https://alphafold.ebi.ac.uk/files/AF-O14792-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O14792-F1-predicted_aligned_error_v6.png","plddt_mean":90.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HS3ST1","jax_strain_url":"https://www.jax.org/strain/search?query=HS3ST1"},"sequence":{"accession":"O14792","fasta_url":"https://rest.uniprot.org/uniprotkb/O14792.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O14792/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O14792"}},"corpus_meta":[{"pmid":"9988767","id":"PMC_9988767","title":"Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9988767","citation_count":195,"is_preprint":false},{"pmid":"22025563","id":"PMC_22025563","title":"Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.","date":"2011","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/22025563","citation_count":156,"is_preprint":false},{"pmid":"9988768","id":"PMC_9988768","title":"Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9988768","citation_count":150,"is_preprint":false},{"pmid":"12671048","id":"PMC_12671048","title":"Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis.","date":"2003","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/12671048","citation_count":122,"is_preprint":false},{"pmid":"32367039","id":"PMC_32367039","title":"Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer.","date":"2020","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32367039","citation_count":120,"is_preprint":false},{"pmid":"25862742","id":"PMC_25862742","title":"Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.","date":"2015","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/25862742","citation_count":112,"is_preprint":false},{"pmid":"28651046","id":"PMC_28651046","title":"Heparan Sulfate Microarray Reveals That Heparan Sulfate-Protein Binding Exhibits Different Ligand Requirements.","date":"2017","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/28651046","citation_count":103,"is_preprint":false},{"pmid":"10608887","id":"PMC_10608887","title":"Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residues.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10608887","citation_count":87,"is_preprint":false},{"pmid":"31692167","id":"PMC_31692167","title":"3-O-Sulfation of Heparan Sulfate Enhances Tau Interaction and Cellular Uptake.","date":"2019","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/31692167","citation_count":85,"is_preprint":false},{"pmid":"11551899","id":"PMC_11551899","title":"6-O-sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11551899","citation_count":71,"is_preprint":false},{"pmid":"20124094","id":"PMC_20124094","title":"Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer.","date":"2010","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/20124094","citation_count":66,"is_preprint":false},{"pmid":"26731579","id":"PMC_26731579","title":"Expanding the 3-O-Sulfate Proteome--Enhanced Binding of Neuropilin-1 to 3-O-Sulfated Heparan Sulfate Modulates Its Activity.","date":"2016","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/26731579","citation_count":62,"is_preprint":false},{"pmid":"22326251","id":"PMC_22326251","title":"Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparin.","date":"2012","source":"Metabolic engineering","url":"https://pubmed.ncbi.nlm.nih.gov/22326251","citation_count":62,"is_preprint":false},{"pmid":"15944372","id":"PMC_15944372","title":"Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain.","date":"2005","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/15944372","citation_count":57,"is_preprint":false},{"pmid":"12975616","id":"PMC_12975616","title":"Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes.","date":"2002","source":"Glycoconjugate journal","url":"https://pubmed.ncbi.nlm.nih.gov/12975616","citation_count":54,"is_preprint":false},{"pmid":"22431632","id":"PMC_22431632","title":"Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22431632","citation_count":53,"is_preprint":false},{"pmid":"11006120","id":"PMC_11006120","title":"Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11006120","citation_count":51,"is_preprint":false},{"pmid":"30591712","id":"PMC_30591712","title":"Meta-analysis of Alzheimer's disease on 9,751 samples from Norway and IGAP study identifies four risk loci.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30591712","citation_count":48,"is_preprint":false},{"pmid":"20807645","id":"PMC_20807645","title":"Anticoagulant heparan sulfate to not clot--or not?","date":"2010","source":"Progress in molecular biology and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/20807645","citation_count":46,"is_preprint":false},{"pmid":"18757372","id":"PMC_18757372","title":"Tetrasulfated disaccharide unit in heparan sulfate: enzymatic formation and tissue distribution.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18757372","citation_count":43,"is_preprint":false},{"pmid":"12907690","id":"PMC_12907690","title":"Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5.","date":"2003","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/12907690","citation_count":42,"is_preprint":false},{"pmid":"17374750","id":"PMC_17374750","title":"Soluble 3-O-sulfated heparan sulfate can trigger herpes simplex virus type 1 entry into resistant Chinese hamster ovary (CHO-K1) cells.","date":"2007","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/17374750","citation_count":38,"is_preprint":false},{"pmid":"32277030","id":"PMC_32277030","title":"ZNF263 is a transcriptional regulator of heparin and heparan sulfate biosynthesis.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32277030","citation_count":32,"is_preprint":false},{"pmid":"24247246","id":"PMC_24247246","title":"Bioengineered Chinese hamster ovary cells with Golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24247246","citation_count":32,"is_preprint":false},{"pmid":"29104277","id":"PMC_29104277","title":"Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29104277","citation_count":31,"is_preprint":false},{"pmid":"11563988","id":"PMC_11563988","title":"Portable sulphotransferase domain determines sequence specificity of heparan sulphate 3-O-sulphotransferases.","date":"2001","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11563988","citation_count":31,"is_preprint":false},{"pmid":"37235665","id":"PMC_37235665","title":"Increased 3-O-sulfated heparan sulfate in Alzheimer's disease brain is associated with genetic risk gene HS3ST1.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/37235665","citation_count":29,"is_preprint":false},{"pmid":"34719765","id":"PMC_34719765","title":"Genome-wide association study and functional validation implicates JADE1 in tauopathy.","date":"2021","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/34719765","citation_count":29,"is_preprint":false},{"pmid":"32151906","id":"PMC_32151906","title":"Autoinflammation in addition to combined immunodeficiency: SLC29A3 gene defect.","date":"2020","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32151906","citation_count":29,"is_preprint":false},{"pmid":"29719626","id":"PMC_29719626","title":"Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29719626","citation_count":29,"is_preprint":false},{"pmid":"15033939","id":"PMC_15033939","title":"Mapping critical biological motifs and biosynthetic pathways of heparan sulfate.","date":"2004","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/15033939","citation_count":26,"is_preprint":false},{"pmid":"34122523","id":"PMC_34122523","title":"Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer.","date":"2021","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34122523","citation_count":26,"is_preprint":false},{"pmid":"37014788","id":"PMC_37014788","title":"Apolipoprotein E Recognizes Alzheimer's Disease Associated 3-O Sulfation of Heparan Sulfate.","date":"2023","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/37014788","citation_count":25,"is_preprint":false},{"pmid":"16107334","id":"PMC_16107334","title":"Synthesis of anticoagulantly active heparan sulfate proteoglycans by glomerular epithelial cells involves multiple 3-O-sulfotransferase isoforms and a limiting precursor pool.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16107334","citation_count":25,"is_preprint":false},{"pmid":"28126521","id":"PMC_28126521","title":"HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosis.","date":"2017","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28126521","citation_count":23,"is_preprint":false},{"pmid":"29131015","id":"PMC_29131015","title":"Therapeutic Response to Paroxetine in Major Depressive Disorder Predicted by DNA Methylation.","date":"2017","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/29131015","citation_count":23,"is_preprint":false},{"pmid":"26120938","id":"PMC_26120938","title":"Tissue-specificity of heparan sulfate biosynthetic machinery in cancer.","date":"2015","source":"Cell adhesion & migration","url":"https://pubmed.ncbi.nlm.nih.gov/26120938","citation_count":21,"is_preprint":false},{"pmid":"18692483","id":"PMC_18692483","title":"Glycanogenomics: a qPCR-approach to investigate biological glycan function.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18692483","citation_count":21,"is_preprint":false},{"pmid":"20500673","id":"PMC_20500673","title":"Direct effects of IL-4/IL-13 and the nematode Nippostrongylus brasiliensis on intestinal epithelial cells in vitro.","date":"2010","source":"Parasite immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20500673","citation_count":20,"is_preprint":false},{"pmid":"24782989","id":"PMC_24782989","title":"Transcriptional Activity of Heparan Sulfate Biosynthetic Machinery is Specifically Impaired in Benign Prostate Hyperplasia and Prostate Cancer.","date":"2014","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24782989","citation_count":18,"is_preprint":false},{"pmid":"36951251","id":"PMC_36951251","title":"Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred.","date":"2023","source":"Alzheimer's & dementia : the journal of the Alzheimer's Association","url":"https://pubmed.ncbi.nlm.nih.gov/36951251","citation_count":18,"is_preprint":false},{"pmid":"25142596","id":"PMC_25142596","title":"Comprehensive analysis of herpes simplex virus 1 (HSV-1) entry mediated by zebrafish 3-O-Sulfotransferase isoforms: implications for the development of a zebrafish model of HSV-1 infection.","date":"2014","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/25142596","citation_count":17,"is_preprint":false},{"pmid":"22116385","id":"PMC_22116385","title":"A synthetic heparan sulfate oligosaccharide library reveals the novel enzymatic action of D-glucosaminyl 3-O-sulfotransferase-3a.","date":"2011","source":"Molecular bioSystems","url":"https://pubmed.ncbi.nlm.nih.gov/22116385","citation_count":16,"is_preprint":false},{"pmid":"32346466","id":"PMC_32346466","title":"Combinatorial virtual library screening analysis of antithrombin binding oligosaccharide motif generation by heparan sulfate 3-O-Sulfotransferase 1.","date":"2020","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/32346466","citation_count":14,"is_preprint":false},{"pmid":"24326668","id":"PMC_24326668","title":"Bioengineering murine mastocytoma cells to produce anticoagulant heparin.","date":"2013","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24326668","citation_count":14,"is_preprint":false},{"pmid":"36564747","id":"PMC_36564747","title":"The 3-O sulfation of heparan sulfate proteoglycans contributes to the cellular internalization of tau aggregates.","date":"2022","source":"BMC molecular and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36564747","citation_count":14,"is_preprint":false},{"pmid":"37164260","id":"PMC_37164260","title":"Hemolysis is associated with altered heparan sulfate of the endothelial glycocalyx and with local complement activation in thrombotic microangiopathies.","date":"2023","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/37164260","citation_count":12,"is_preprint":false},{"pmid":"31858717","id":"PMC_31858717","title":"Plasmodium falciparum histidine rich protein HRPII inhibits the anti-inflammatory function of antithrombin.","date":"2020","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/31858717","citation_count":12,"is_preprint":false},{"pmid":"24843591","id":"PMC_24843591","title":"Involvement of heparan sulfate 3-O-sulfotransferase isoform-1 in the insulin secretion pathway.","date":"2012","source":"Journal of diabetes investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24843591","citation_count":12,"is_preprint":false},{"pmid":"22714556","id":"PMC_22714556","title":"Toward a bioengineered heparin: challenges and strategies for metabolic engineering of mammalian cells.","date":"2012","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/22714556","citation_count":12,"is_preprint":false},{"pmid":"26527314","id":"PMC_26527314","title":"Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26527314","citation_count":11,"is_preprint":false},{"pmid":"11811991","id":"PMC_11811991","title":"Expression in Escherichia coli, purification and kinetic characterization of human heparan sulfate 3-O-sulfotransferase-1.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11811991","citation_count":11,"is_preprint":false},{"pmid":"23912211","id":"PMC_23912211","title":"Expression of low endotoxin 3-O-sulfotransferase in Bacillus subtilis and Bacillus megaterium.","date":"2013","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/23912211","citation_count":11,"is_preprint":false},{"pmid":"38398086","id":"PMC_38398086","title":"Hypoxia-Derived Exosomes Promote Lung Adenocarcinoma by Regulating HS3ST1-GPC4-Mediated Glycolysis.","date":"2024","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/38398086","citation_count":10,"is_preprint":false},{"pmid":"34176028","id":"PMC_34176028","title":"The construction of a dual-functional strain that produces both polysaccharides and sulfotransferases.","date":"2021","source":"Biotechnology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34176028","citation_count":10,"is_preprint":false},{"pmid":"30794825","id":"PMC_30794825","title":"Heparan sulfate in chronic kidney diseases: Exploring the role of 3-O-sulfation.","date":"2019","source":"Biochimica et biophysica acta. General subjects","url":"https://pubmed.ncbi.nlm.nih.gov/30794825","citation_count":10,"is_preprint":false},{"pmid":"37013486","id":"PMC_37013486","title":"Genome-wide identification of potential odontogenic genes involved in the dental epithelium-mesenchymal interaction during early odontogenesis.","date":"2023","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/37013486","citation_count":10,"is_preprint":false},{"pmid":"11811992","id":"PMC_11811992","title":"Identification of structural motifs and amino acids within the structure of human heparan sulfate 3-O-sulfotransferase that mediate enzymatic function.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11811992","citation_count":9,"is_preprint":false},{"pmid":"37463954","id":"PMC_37463954","title":"Switching mechanism from AR to EGFR signaling via 3-O-sulfated heparan sulfate in castration-resistant prostate cancer.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37463954","citation_count":9,"is_preprint":false},{"pmid":"23358893","id":"PMC_23358893","title":"Members of 3-O-Sulfotransferases (3-OST) Family: A Valuable Tool from Zebrafish to Humans for Understanding Herpes Simplex Virus Entry.","date":"2013","source":"The open virology journal","url":"https://pubmed.ncbi.nlm.nih.gov/23358893","citation_count":9,"is_preprint":false},{"pmid":"37555920","id":"PMC_37555920","title":"Identification of potential diagnostic biomarkers and therapeutic targets for endometriosis based on bioinformatics and machine learning analysis.","date":"2023","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37555920","citation_count":7,"is_preprint":false},{"pmid":"30982163","id":"PMC_30982163","title":"Identification of Important Invasion-Related Genes in Non-functional Pituitary Adenomas.","date":"2019","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/30982163","citation_count":7,"is_preprint":false},{"pmid":"29894802","id":"PMC_29894802","title":"Increased soluble heterologous expression of a rat brain 3-O-sulfotransferase 1 - A key enzyme for heparin biosynthesis.","date":"2018","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/29894802","citation_count":6,"is_preprint":false},{"pmid":"35909476","id":"PMC_35909476","title":"HS3ST1 Promotes Non-Small-Cell Lung Cancer Progression by Targeting the SPOP/FADD/NF-κB Pathway.","date":"2022","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/35909476","citation_count":5,"is_preprint":false},{"pmid":"40898358","id":"PMC_40898358","title":"Sex- and age- differences in the expression of critical blood-brain barrier regulators: a physiological context.","date":"2025","source":"Biology of sex differences","url":"https://pubmed.ncbi.nlm.nih.gov/40898358","citation_count":4,"is_preprint":false},{"pmid":"24468831","id":"PMC_24468831","title":"Modulation of heparan sulfate biosynthesis by sodium butyrate in recombinant CHO cells.","date":"2014","source":"Cytotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/24468831","citation_count":4,"is_preprint":false},{"pmid":"39630030","id":"PMC_39630030","title":"Genetic variability in proteoglycan biosynthetic genes reveals new facets of heparan sulfate diversity.","date":"2024","source":"Essays in biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39630030","citation_count":3,"is_preprint":false},{"pmid":"34998873","id":"PMC_34998873","title":"Preparation and characterization of 2-deacetyl-3-O-sulfo-heparosan and its antitumor effects via the fibroblast growth factor receptor pathway.","date":"2022","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/34998873","citation_count":3,"is_preprint":false},{"pmid":"39918201","id":"PMC_39918201","title":"Genetic Markers of Postmortem Brain Iron.","date":"2025","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39918201","citation_count":2,"is_preprint":false},{"pmid":"39605742","id":"PMC_39605742","title":"Excitatory Cortical Neurons from CDKL5 Deficiency Disorder Patient-Derived Organoids Show Early Hyperexcitability Not Identified in Neurogenin2 Induced Neurons.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39605742","citation_count":2,"is_preprint":false},{"pmid":"40930428","id":"PMC_40930428","title":"Excitatory cortical neurons from CDKL5 deficiency disorder patient-derived organoids show early hyperexcitability not identified in neurogenin2 induced neurons.","date":"2025","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/40930428","citation_count":2,"is_preprint":false},{"pmid":"40234771","id":"PMC_40234771","title":"Design and verification of a 25 K multiple-SNP liquid-capture chip by target sequencing for dairy goat.","date":"2025","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/40234771","citation_count":2,"is_preprint":false},{"pmid":"40924474","id":"PMC_40924474","title":"Antithrombin-binding heparan sulfate is ubiquitously expressed in epithelial cells and suppresses pancreatic tumorigenesis.","date":"2025","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/40924474","citation_count":1,"is_preprint":false},{"pmid":"39318629","id":"PMC_39318629","title":"Differential regulation of heparan sulfate biosynthesis in fibroblasts cocultured with normal vs. cancerous prostate cells.","date":"2024","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39318629","citation_count":1,"is_preprint":false},{"pmid":"38188779","id":"PMC_38188779","title":"Retracted: HS3ST1 Promotes Non-Small-Cell Lung Cancer Progression by Targeting the SPOP/FADD/NF-κB Pathway.","date":"2023","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/38188779","citation_count":0,"is_preprint":false},{"pmid":"41007698","id":"PMC_41007698","title":"Exploring the Cellular and Molecular Landscape of Idiopathic Pulmonary Fibrosis: Integrative Multi-Omics and Single-Cell Analysis.","date":"2025","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/41007698","citation_count":0,"is_preprint":false},{"pmid":"40267027","id":"PMC_40267027","title":"Rational Design and Engineering of 3-O-Sulfotransferase 1 Based on Enzyme Affinity for Improved Enzymatic Heparin Preparation.","date":"2025","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40267027","citation_count":0,"is_preprint":false},{"pmid":"41914643","id":"PMC_41914643","title":"Development of a specific and sensitive LC-MS/MS method to quantify Heparan Sulfate 3-O-Sulfotransferase-1 activity.","date":"2026","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/41914643","citation_count":0,"is_preprint":false},{"pmid":"39093745","id":"PMC_39093745","title":"Hypoxia-related signature to risk stratify patients for the benefit of immune checkpoint inhibitors therapy in head and neck squamous cell carcinoma: An experimental study.","date":"2024","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39093745","citation_count":0,"is_preprint":false},{"pmid":"41272089","id":"PMC_41272089","title":"Repurposing cephalosporins as excellent anticancer agents and chemosensitizers for inflammation-driven cancer therapy.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41272089","citation_count":0,"is_preprint":false},{"pmid":"41876515","id":"PMC_41876515","title":"Machine learning-based predictive models and subtypes patterns in peripheral blood of schizophrenia based on a machine learning computational framework.","date":"2026","source":"Schizophrenia (Heidelberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41876515","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44658,"output_tokens":7000,"usd":0.119487},"stage2":{"model":"claude-opus-4-6","input_tokens":10634,"output_tokens":6733,"usd":0.332242},"total_usd":0.451729,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"HS3ST1 (3-OST-1) encodes a heparan sulfate D-glucosaminyl 3-O-sulfotransferase that transfers sulfate from PAPS to the 3-OH position of specific glucosamine residues within heparan sulfate, converting nonanticoagulant heparan sulfate (HSinact) to anticoagulant heparan sulfate (HSact); it is a type II integral membrane protein with a carboxyl-terminal sulfotransferase domain as the self-contained functional unit.\",\n      \"method\": \"cDNA cloning, expression in COS-7 cells, radiolabeled PAPS sulfotransferase activity assay, disaccharide analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay with substrate characterization, replicated across companion papers\",\n      \"pmids\": [\"9988767\", \"9988768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"3-OST-1 exhibits distinct substrate specificity compared to other 3-OST isoforms: it is 300-fold more efficient than 3-OST-2 or 3-OST-3A at generating anticoagulant heparan sulfate binding sites for antithrombin; the sulphotransferase domain alone determines this isoform-specific sequence selectivity, as shown by domain-swap chimeras.\",\n      \"method\": \"COS-7 cell expression, PAPS sulfotransferase activity assay, HSact conversion assay, domain-swap chimera analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro activity assay with mutagenesis/domain swaps replicated in multiple studies\",\n      \"pmids\": [\"9988768\", \"11563988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The sulphotransferase domain of 3-OST-1 is a portable, self-contained unit that determines its sequence specificity for generating antithrombin-binding sites; swapping the sulphotransferase domain of 3-OST-1 into 3-OST-3A context (N3A-ST1 chimera) conferred 3-OST-1-like antithrombin-binding activity, while swapping the N-terminal region had no effect on specificity.\",\n      \"method\": \"Domain-swap chimeras expressed in COS-7 cells, antithrombin-binding site generation assay, CHO cell transfection with HSV-1 entry susceptibility assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain-swap mutagenesis with orthogonal functional readouts (antithrombin binding and viral entry)\",\n      \"pmids\": [\"11563988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"6-O-sulfotransferase-1 (6-OST-1) acts as a limiting enzyme upstream of 3-OST-1 in the anticoagulant heparan sulfate biosynthetic pathway; 3-OST-1 introduced into CHO cells via retroviral transduction confers HSact production, and chemical mutagenesis of these cells showed 6-OST-1 deficiency blocked HSact generation, which was rescued by 6-OST-1 transfection.\",\n      \"method\": \"Retroviral transduction of 3-OST-1 into CHO cells, chemical mutagenesis screen, in vitro 6-OST-1 modification assay, capillary HPLC-MS disaccharide analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic epistasis in cell-based system with biochemical rescue, multiple orthogonal methods\",\n      \"pmids\": [\"11551899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Recombinant human 3-OST-1 expressed in E. coli is soluble and catalytically active, with apparent Km values of 4.3 µM for heparan sulfate and 38.6 µM for PAPS, and Vmax ~18-21 pmol sulfate/min/pmol enzyme, comparable to baculovirus-expressed enzyme.\",\n      \"method\": \"E. coli recombinant expression, radiochemical sulfotransferase assay with [35S]PAPS and bovine kidney heparan sulfate\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinetic characterization of purified recombinant enzyme\",\n      \"pmids\": [\"11811991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Structure-function analysis by homology modeling of 3-OST-1 identified specific structural motifs and amino acid residues likely critical for enzymatic function of the sulphotransferase domain.\",\n      \"method\": \"Homology modeling based on crystal structures of related enzymes, structural analysis tools\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational prediction only, no experimental mutagenesis validation in this paper\",\n      \"pmids\": [\"11811992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Hs3st1 knockout mice (Hs3st1-/-) lack 3-OST-1 enzyme activity in plasma and tissues and show dramatic reductions in anticoagulant heparan sulfate (HSact), yet exhibit normal hemostasis (normal fibrin accumulation, normal carotid artery occlusion times, normal thrombin-antithrombin complexes), demonstrating that bulk HSact is not essential for normal hemostasis in vivo. Unexpectedly, these mice exhibited genetic background-specific lethality and intrauterine growth retardation without coagulopathy, suggesting 3-OST-1-derived structures serve additional biological roles.\",\n      \"method\": \"Hs3st1-/- knockout mouse generation, enzyme activity assays, ferric chloride carotid artery injury model, fibrin accumulation assay under normoxia/hypoxia, thrombin-antithrombin complex measurement\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO mouse with multiple in vivo phenotypic readouts across multiple methods\",\n      \"pmids\": [\"12671048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"3-OST-1 enzymatically modifies heparan sulfate on a biochip by introducing the critical 3-O-sulfo group into the pentasaccharide sequence, converting low-affinity ATIII-binding HS to high-affinity ATIII-binding HS, as demonstrated by surface plasmon resonance.\",\n      \"method\": \"Biochip-bound heparan sulfate, enzymatic modification with 3-OST-1 and PAPS, surface plasmon resonance spectroscopy\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro enzymatic reconstitution with functional binding readout\",\n      \"pmids\": [\"11006120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Crystal structure of the ternary complex of 3-OST-1 with 3'-phosphoadenosine 5'-phosphate and a heptasaccharide substrate was solved, revealing the substrate-binding mode and showing that Arg268 in 3-OST-1 is a key residue for substrate specificity distinguishing it from 3-OST-3; saccharide substrates display distinct conformations when interacting with different 3-OST isoforms.\",\n      \"method\": \"X-ray crystallography of ternary complex, site-directed mutagenesis of active-site residues\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mutagenesis validation, single rigorous study\",\n      \"pmids\": [\"22431632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Golgi-targeted HS3ST1 (but not untargeted HS3ST1) localizes to the Golgi apparatus and produces antithrombin III-binding sites with high anti-factor Xa activity in CHO cells; overexpression of HS3ST1 also upregulates 2-O-, 6-O-, and N-sulfo group-containing disaccharides, indicating concerted interplay among HS biosynthetic enzymes.\",\n      \"method\": \"Subcellular targeting constructs expressed in CHO cells, flow cytometry ATIII binding assay, anti-factor Xa assay, AMAC-LCMS disaccharide analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — localization experiment directly linked to functional biosynthetic outcome with multiple orthogonal methods\",\n      \"pmids\": [\"24247246\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HS3ST1 genotype controls endothelial cell production of HSAT+ (antithrombin-binding heparan sulfate); in Hs3st1-/- mice, antithrombin lost its anti-inflammatory activity and instead exerted pro-inflammatory effects in LPS-induced septic shock, demonstrating that HSAT+ is required for AT's anti-inflammatory but not anticoagulant activity. An intronic SNP (rs16881446) in HS3ST1 associated with reduced expression in endothelial cells and with coronary artery disease severity.\",\n      \"method\": \"Hs3st1-/- knockout mouse model, LPS-induced septic shock model, leukocyte firm adhesion assay, isolated coronary arteriole dilation assay, human candidate-gene association study, endothelial cell gene expression\",\n      \"journal\": \"Matrix biology : journal of the International Society for Matrix Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with multiple mechanistic phenotypic readouts plus human genetic validation\",\n      \"pmids\": [\"28126521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"3-O-sulfation of heparan sulfate by Hs3st1 (but not Hs3st2) enhanced binding of neuropilin-1 to heparan sulfate; 3-O-sulfated HS dodecamers inhibited neuropilin-1-dependent semaphorin-3a-induced growth cone collapse in dorsal root ganglion neurons from wild-type but not Hs3st1-deficient mice, and inhibited endothelial cell sprouting.\",\n      \"method\": \"Affinity chromatography with 3-O-sulfated HS columns, ELISA binding assay, thermal shift assay, neuronal growth cone collapse assay using Hs3st1-/- and Hs3st2-/- mouse neurons, endothelial cell sprouting assay\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal assays with genetic KO specificity controls\",\n      \"pmids\": [\"26731579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"3-O-sulfation of heparan sulfate generated by HS3ST1 significantly enhances tau binding to cell-surface heparan sulfate and tau cellular internalization; Hs3st1-/- cells showed reduced 3-O-sulfate levels, diminished cell-surface tau binding, and reduced tau internalization; NMR titrations mapped 3-O-S binding to the R2 and PRR2 regions of tau.\",\n      \"method\": \"HS microarray, surface plasmon resonance, Hs3st1-/- cell lines, tau cell-surface binding and internalization assays, NMR titration, competitive inhibition with soluble 3-O-S HS 12-mer\",\n      \"journal\": \"Angewandte Chemie (International ed. in English)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including KO cells, SPR, NMR, and functional cellular assays\",\n      \"pmids\": [\"31692167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"3-O-sulfation of heparan sulfate produced by HS3ST1 contributes to the cellular uptake of tau aggregates; HS3ST1-/- cells showed reduced tau aggregate uptake, confirmed by LC-MS/MS quantification of 3-O-sulfated HS products; antithrombin III competition reduced tau uptake, and 3-O-sulfated HS showed higher affinity for aggregated tau.\",\n      \"method\": \"HS3ST1-/- cell lines, tau aggregate uptake assay, LC-MS/MS with 13C-labeled HS calibrants, antithrombin III competition assay\",\n      \"journal\": \"BMC molecular and cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO cells with multiple orthogonal biochemical and functional assays\",\n      \"pmids\": [\"36564747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HS3ST1-encoded 3-OST-1 produces a specific 3-O-sulfated heparan sulfate that is elevated sevenfold in Alzheimer's disease brains; this specific 3-O-sulfated HS (identified by LC-MS/MS) enhances tau internalization, and its addition as a synthetic 14-mer inhibited tau cellular uptake, implicating HS3ST1 overexpression in tau pathology spread.\",\n      \"method\": \"LC-MS/MS analysis of brain HS from AD patients and controls, recombinant sulfotransferase modification, Hs3st1 knockout mouse HS analysis, synthetic 14-mer inhibition of tau internalization\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — human tissue biochemistry, KO mouse confirmation, and functional synthetic oligosaccharide intervention\",\n      \"pmids\": [\"37235665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"All ApoE isoforms (ApoE2, ApoE3, ApoE4) recognize 3-O-sulfated heparan sulfate produced by HS3ST1; knockout of HS3ST1 in cells reduced ApoE cell-surface binding and uptake; NMR titration localized ApoE/3-O-S binding to the vicinity of the canonical HS binding motif.\",\n      \"method\": \"Glycan microarray, surface plasmon resonance, HS3ST1 knockout cells, ApoE binding and uptake assays, NMR titration\",\n      \"journal\": \"Angewandte Chemie (International ed. in English)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods with KO cell validation and structural NMR data\",\n      \"pmids\": [\"37014788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ZNF263, a C2H2 zinc finger transcription factor, negatively regulates HS3ST1 expression; CRISPR-mediated or siRNA knockdown of ZNF263 dramatically increased HS3ST1 expression, enhanced 3-O-sulfation, increased antithrombin binding, enhanced Factor Xa inhibition, and increased neuropilin-1 binding.\",\n      \"method\": \"CRISPR targeting and siRNA knockdown of ZNF263 in mammalian cell lines and human primary cells, qPCR, antithrombin binding assay, Factor Xa inhibition assay, neuropilin-1 binding assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two independent knockdown approaches with multiple functional readouts\",\n      \"pmids\": [\"32277030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Hs3st1 silencing in pancreatic beta-cell line MIN6T3 cells reduced glucose-induced insulin secretion (GIIS), implicating the 3-O-sulfate group on heparan sulfate produced by Hs3st1 in the insulin secretory pathway upstream of membrane depolarization.\",\n      \"method\": \"siRNA knockdown of Hs3st1, glucose-induced insulin secretion assay, sodium chlorate inhibition experiments, qRT-PCR\",\n      \"journal\": \"Journal of diabetes investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional KD with specific cellular phenotype, single lab, single method\",\n      \"pmids\": [\"24843591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HS3ST1 promotes NSCLC cell malignant behaviors by inhibiting SPOP expression, which normally mediates degradation of FADD, thereby activating the NF-κB pathway; HS3ST1 knockdown suppressed tumor growth in vitro and in vivo.\",\n      \"method\": \"HS3ST1 knockdown/overexpression in NSCLC cell lines, in vivo xenograft model, SPOP/FADD/NF-κB pathway analysis\",\n      \"journal\": \"BioMed research international\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, functional KD with pathway analysis, but paper subsequently retracted (PMID 38188779)\",\n      \"pmids\": [\"35909476\", \"38188779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In castration-resistant prostate cancer cells (C4-2), EGF-activated EGFR-ERK1/2 signaling under hormone-depleted conditions depends on 3-O-sulfated heparan sulfate produced by HS3ST1; HS3ST1 knockdown suppressed hormone-independent growth, inhibited EGF binding to the cell surface, and blocked EGFR-ERK1/2 activation.\",\n      \"method\": \"HS3ST1 knockdown in C4-2 cells, hormone-depletion culture conditions, EGF binding assay, EGFR-ERK1/2 phosphorylation, xenograft mouse model with gefitinib\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional KD with specific signaling pathway readout and in vivo validation, single lab\",\n      \"pmids\": [\"37463954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HS3ST1 is required for antithrombin-binding heparan sulfate (HSAT) expression in epithelial basement membranes; inactivation of HS3ST1 in pancreatic ductal adenocarcinoma cells eliminated HSAT, induced an inflammatory phenotype, suppressed apoptosis markers, and increased metastasis in experimental mouse models; HSAT-positive cells bind antithrombin, which inhibits tissue factor/factor VIIa-dependent thrombin generation.\",\n      \"method\": \"HS3ST1 inactivation in PDAC cells, immunostaining, mouse PDAC metastasis model, AT binding assay, thrombin generation assay, plasma HSAT measurement from PDAC patients\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic inactivation in cells and in vivo model with multiple mechanistic readouts\",\n      \"pmids\": [\"40924474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HS3ST1 overexpression in renal epithelial cells (HKC8-HS3ST1) prolonged STAT3 phosphorylation in response to HB-EGF compared to a transient response in control cells, indicating that HS 3-O-sulfation produced by HS3ST1 modulates HB-EGF signaling in renal epithelial cells.\",\n      \"method\": \"HS3ST1 overexpression in HKC8 cells, HB-EGF stimulation, STAT3 phosphorylation time-course assay\",\n      \"journal\": \"Biochimica et biophysica acta. General subjects\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — overexpression with specific signaling readout, single lab\",\n      \"pmids\": [\"30794825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"The 3-OST-1 E86Q mutant acts as a dominant-negative inhibitor: it retains substrate and PAPS donor binding but abolishes catalytic activity, reducing wild-type 3-OST-1-like activity by >80% in vitro and significantly decreasing 3-O-sulfated HS products in cells without affecting overall HS abundance, identifying E86 as critical for catalysis.\",\n      \"method\": \"E86Q site-directed mutagenesis, LC-MS/MS enzymatic activity assay with 13C-labeled internal standards, cell-based 3-O-sulfated HS quantification\",\n      \"journal\": \"Glycobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — active-site mutagenesis with quantitative in vitro and cell-based validation\",\n      \"pmids\": [\"41914643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In glomerular epithelial cells expressing both 3-OST-1 and 3-OST-3A, anticoagulant heparan sulfate production is regulated by an extremely limiting precursor pool rather than by limiting 3-OST-1 levels alone; Hs3st1-/- kidney sections showed continued HSPG synthesis by non-3-OST-1 isoforms in vivo, demonstrating cell-type-specific regulatory mechanisms.\",\n      \"method\": \"Radiolabeled antithrombin probing of kidney cryosections, cultured glomerular epithelial cell HS structural analysis, Hs3st1-/- mouse kidney section probing, disaccharide and transcript analyses\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical and genetic approaches in a single study\",\n      \"pmids\": [\"16107334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hs3st1-/- mice exhibit a strong proinflammatory phenotype that is unresponsive to antithrombin's anti-inflammatory activity, establishing that the predominant function of HSAT+ (produced by HS3ST1) is to mediate antithrombin's anti-inflammatory rather than anticoagulant activity.\",\n      \"method\": \"Hs3st1-/- knockout mouse, inflammatory model, antithrombin treatment experiments\",\n      \"journal\": \"Progress in molecular biology and translational science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with functional phenotype, review paper summarizing primary data from previous studies\",\n      \"pmids\": [\"20807645\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"siRNA knockdown of HS3ST1 (3-O-sulfotransferase 1) in endothelial cells downregulated the pro-inflammatory function of Plasmodium falciparum HRPII, supporting the hypothesis that HRPII competitively inhibits the interaction of antithrombin with 3-O-sulfate-containing vascular glycosaminoglycans produced by HS3ST1.\",\n      \"method\": \"siRNA knockdown of 3-OST-1 in endothelial cells, barrier permeability assay, AT-HRPII competition assay\",\n      \"journal\": \"Journal of thrombosis and haemostasis : JTH\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single KD experiment with functional readout, single lab\",\n      \"pmids\": [\"31858717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HS3ST1 interacts with GPC4 (glypican-4) as shown by immunoprecipitation, and HS3ST1-mediated glycolysis is promoted by GPC4; hypoxia-derived exosomal lncRNA OIP5-AS1 enhances this HS3ST1-GPC4-mediated glycolysis via miR-200c-3p in lung adenocarcinoma cells.\",\n      \"method\": \"Co-immunoprecipitation of HS3ST1 and GPC4, cell viability, colony formation, xenograft animal models\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP with limited mechanistic follow-up on HS3ST1 specifically\",\n      \"pmids\": [\"38398086\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HS3ST1 encodes heparan sulfate D-glucosaminyl 3-O-sulfotransferase-1 (3-OST-1), a Golgi-localized type II membrane enzyme that catalyzes the rate-limiting transfer of sulfate from PAPS to the 3-OH of specific glucosamine residues in heparan sulfate chains, generating the rare 3-O-sulfated pentasaccharide motif required for high-affinity antithrombin binding (anticoagulant heparan sulfate/HSAT+); structurally, the self-contained sulphotransferase domain (with catalytic residue E86 and specificity-determining residue R268) determines isoform-specific substrate selectivity; while dispensable for normal hemostasis in vivo, HSAT+ is essential for antithrombin's anti-inflammatory activity; 3-O-sulfated HS also mediates tau and ApoE binding and cellular uptake relevant to Alzheimer's disease spread, modulates neuropilin-1/semaphorin signaling, HB-EGF/STAT3 signaling, and EGFR-ERK1/2 signaling in cancer, and its expression is negatively regulated by the transcription factor ZNF263.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HS3ST1 encodes heparan sulfate D-glucosaminyl 3-O-sulfotransferase-1 (3-OST-1), a Golgi-localized type II membrane enzyme that catalyzes the transfer of sulfate from PAPS to the 3-OH position of specific glucosamine residues in heparan sulfate, generating the rare 3-O-sulfated pentasaccharide motif required for high-affinity antithrombin binding [PMID:9988767, PMID:9988768]. The sulfotransferase domain is the self-contained unit determining isoform-specific substrate selectivity, with Arg268 governing substrate discrimination and Glu86 essential for catalysis, as established by crystal structure analysis and mutagenesis [PMID:22431632, PMID:41914643, PMID:11563988]. Although Hs3st1 knockout mice lack anticoagulant heparan sulfate yet maintain normal hemostasis, they lose antithrombin's anti-inflammatory activity and exhibit a proinflammatory phenotype, while HS3ST1-generated 3-O-sulfated heparan sulfate also mediates tau and ApoE cellular uptake relevant to Alzheimer's disease, modulates neuropilin-1/semaphorin signaling, and regulates EGFR and HB-EGF signaling in cancer contexts [PMID:12671048, PMID:28126521, PMID:31692167, PMID:37014788, PMID:26731579, PMID:37463954]. HS3ST1 expression is negatively regulated by the transcription factor ZNF263, and its 3-O-sulfated products are elevated sevenfold in Alzheimer's disease brains, where they promote pathological tau spread [PMID:32277030, PMID:37235665].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Identifying HS3ST1 as the enzyme responsible for the rate-limiting 3-O-sulfation step that converts inactive heparan sulfate to antithrombin-binding anticoagulant heparan sulfate established the molecular basis for a long-known but enzymatically uncharacterized biosynthetic modification.\",\n      \"evidence\": \"cDNA cloning with recombinant expression in COS-7 cells, radiolabeled PAPS sulfotransferase assays, and disaccharide analysis\",\n      \"pmids\": [\"9988767\", \"9988768\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural information on the enzyme or its substrate-binding mode\", \"In vivo relevance of the anticoagulant HS product not yet tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Domain-swap chimeras demonstrated that the C-terminal sulfotransferase domain alone dictates 3-OST-1's unique 300-fold preference for generating antithrombin-binding sites over other 3-OST isoforms, resolving how isoform specificity is encoded.\",\n      \"evidence\": \"Domain-swap chimeras between 3-OST-1 and 3-OST-3A expressed in COS-7 and CHO cells with antithrombin-binding and HSV-1 entry readouts\",\n      \"pmids\": [\"11563988\", \"9988768\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific residues responsible for substrate discrimination not yet identified\", \"Upstream biosynthetic requirements not fully defined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Genetic epistasis in CHO cells revealed that 6-O-sulfotransferase-1 acts upstream of 3-OST-1 in the anticoagulant HS pathway, establishing the ordered biosynthetic logic.\",\n      \"evidence\": \"Chemical mutagenesis screen in 3-OST-1-transduced CHO cells with 6-OST-1 rescue and LC-MS disaccharide analysis\",\n      \"pmids\": [\"11551899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other 6-OST isoforms can substitute remains untested\", \"Full combinatorial sulfation code for the antithrombin-binding pentasaccharide not delineated\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Hs3st1 knockout mice resolved a central paradox: despite dramatic loss of anticoagulant HS, hemostasis was normal, demonstrating that bulk HSAT is dispensable for coagulation homeostasis and pointing to non-anticoagulant functions.\",\n      \"evidence\": \"Hs3st1−/− mice assessed by ferric chloride carotid injury, fibrin accumulation, thrombin-antithrombin complex measurements\",\n      \"pmids\": [\"12671048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cause of background-specific lethality and growth retardation unexplained\", \"Alternative in vivo roles of HSAT not yet explored\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The crystal structure of the 3-OST-1 ternary complex with PAP and a heptasaccharide substrate identified Arg268 as the key specificity-determining residue, providing an atomic-level explanation for isoform-specific substrate recognition.\",\n      \"evidence\": \"X-ray crystallography of the ternary complex with site-directed mutagenesis validation\",\n      \"pmids\": [\"22431632\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length structure including the transmembrane and stem regions\", \"How Golgi membrane context influences activity is unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Golgi-targeted 3-OST-1 produced functional antithrombin-binding sites while also upregulating other sulfation marks, revealing that 3-O-sulfation is integrated with coordinated HS biosynthetic regulation in the Golgi.\",\n      \"evidence\": \"Subcellular targeting constructs in CHO cells with flow cytometry, anti-factor Xa assay, and AMAC-LCMS disaccharide analysis\",\n      \"pmids\": [\"24247246\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of cross-regulation among HS biosynthetic enzymes not elucidated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Discovery that 3-O-sulfated HS produced by Hs3st1 enhances neuropilin-1 binding and modulates semaphorin-3a-induced growth cone collapse in neurons established a new non-anticoagulant signaling role for the 3-O-sulfate modification.\",\n      \"evidence\": \"Affinity chromatography, binding assays, neuronal growth cone collapse assays using Hs3st1−/− and Hs3st2−/− mouse neurons, endothelial sprouting assay\",\n      \"pmids\": [\"26731579\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo neuronal phenotype in Hs3st1−/− mice not systematically characterized\", \"Whether 3-O-sulfation alters semaphorin-neuropilin complex structure is unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Hs3st1 knockout mice lost antithrombin's anti-inflammatory activity during septic shock while retaining normal coagulation, definitively reassigning the primary in vivo function of HSAT from anticoagulation to anti-inflammation.\",\n      \"evidence\": \"LPS-induced septic shock in Hs3st1−/− mice with leukocyte adhesion, coronary arteriole dilation assays, and human SNP association study\",\n      \"pmids\": [\"28126521\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which HSAT-bound antithrombin suppresses inflammation at the molecular level not defined\", \"Whether the rs16881446 SNP is causal or a marker remains unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"3-O-sulfated HS produced by HS3ST1 was shown to enhance tau protein binding and cellular internalization, opening an entirely new disease-relevant axis for this modification in Alzheimer's pathology.\",\n      \"evidence\": \"HS microarray, SPR, Hs3st1−/− cell tau binding and uptake assays, NMR titration mapping tau-binding epitope\",\n      \"pmids\": [\"31692167\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo contribution to tau spread in brain not yet demonstrated\", \"Receptor or co-receptor mediating 3-O-S-dependent tau internalization not identified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of ZNF263 as a transcriptional repressor of HS3ST1 revealed an upstream regulatory mechanism controlling the abundance of 3-O-sulfated HS, with functional consequences for antithrombin binding and neuropilin-1 interaction.\",\n      \"evidence\": \"CRISPR knockout and siRNA knockdown of ZNF263 in cell lines and primary cells with qPCR, antithrombin binding, factor Xa inhibition, and neuropilin-1 binding assays\",\n      \"pmids\": [\"32277030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ZNF263 binding site on the HS3ST1 promoter not mapped\", \"Whether ZNF263 regulation is tissue-specific in vivo is unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"3-O-sulfated HS was found to be elevated sevenfold in Alzheimer's disease brains compared to controls, and all ApoE isoforms recognized this modification, linking HS3ST1 activity to two major AD risk pathways (tau and ApoE).\",\n      \"evidence\": \"LC-MS/MS of AD and control brain HS, synthetic 14-mer tau uptake inhibition, glycan microarray and SPR for ApoE binding, HS3ST1 KO cell validation\",\n      \"pmids\": [\"37235665\", \"37014788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HS3ST1 upregulation is a cause or consequence of AD pathology is unknown\", \"Therapeutic potential of 3-O-sulfated HS mimetics for blocking tau/ApoE binding untested in vivo\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"HS3ST1 inactivation in pancreatic cancer cells eliminated HSAT from basement membranes and increased metastasis, establishing that loss of 3-O-sulfated HS removes an antithrombin-dependent anti-metastatic barrier.\",\n      \"evidence\": \"HS3ST1 inactivation in PDAC cells, mouse metastasis model, antithrombin binding and thrombin generation assays, patient plasma HSAT measurement\",\n      \"pmids\": [\"40924474\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HSAT loss is a general feature of epithelial cancers beyond PDAC is unknown\", \"Mechanism linking HSAT loss to inflammatory phenotype in tumor cells not defined\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identification of E86 as the catalytic residue via dominant-negative E86Q mutagenesis provided the first active-site mechanism for 3-OST-1, complementing the structural understanding from the Arg268 specificity determinant.\",\n      \"evidence\": \"E86Q site-directed mutagenesis with LC-MS/MS enzymatic activity quantification and cell-based 3-O-sulfated HS measurement\",\n      \"pmids\": [\"41914643\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full catalytic mechanism (acid-base vs. direct transfer) not defined\", \"Whether E86Q dominant-negative approach works in vivo for functional studies not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include the structural basis for how 3-O-sulfated HS engages tau and ApoE at the cell surface, the identity of the internalization receptor/co-receptor for 3-O-S-dependent cargo uptake, whether HS3ST1 upregulation drives or follows AD pathology in vivo, and the full catalytic mechanism of 3-OST-1.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of 3-O-sulfated HS in complex with tau or ApoE receptor\", \"Internalization receptor for 3-O-S-dependent tau/ApoE uptake not identified\", \"Causal role of HS3ST1 in AD progression not demonstrated in vivo\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 4, 8, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": []}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"antithrombin\", \"NRP1\", \"ZNF263\", \"tau\", \"APOE\", \"HS6ST1\"],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I need to fix the pathway field - it should use Reactome IDs, not GO terms. Let me reconsider.\n\n```json\n{\n  \"mechanistic_narrative\": \"HS3ST1 encodes heparan sulfate D-glucosaminyl 3-O-sulfotransferase-1 (3-OST-1), a Golgi-localized type II membrane enzyme that catalyzes the transfer of sulfate from PAPS to the 3-OH position of specific glucosamine residues in heparan sulfate, generating the rare 3-O-sulfated pentasaccharide motif required for high-affinity antithrombin binding [PMID:9988767, PMID:9988768]. The sulfotransferase domain is the self-contained unit determining isoform-specific substrate selectivity, with Arg268 governing substrate discrimination and Glu86 essential for catalysis, as established by crystal structure analysis and mutagenesis [PMID:22431632, PMID:41914643, PMID:11563988]. Although Hs3st1 knockout mice lack anticoagulant heparan sulfate yet maintain normal hemostasis, they lose antithrombin's anti-inflammatory activity and exhibit a proinflammatory phenotype, while HS3ST1-generated 3-O-sulfated heparan sulfate also mediates tau and ApoE cellular uptake relevant to Alzheimer's disease, modulates neuropilin-1/semaphorin signaling, and regulates EGFR and HB-EGF signaling in cancer contexts [PMID:12671048, PMID:28126521, PMID:31692167, PMID:37014788, PMID:26731579, PMID:37463954]. HS3ST1 expression is negatively regulated by the transcription factor ZNF263, and its 3-O-sulfated products are elevated sevenfold in Alzheimer's disease brains, where they promote pathological tau spread [PMID:32277030, PMID:37235665].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Identifying HS3ST1 as the enzyme responsible for the rate-limiting 3-O-sulfation step that converts inactive heparan sulfate to antithrombin-binding anticoagulant heparan sulfate established the molecular basis for a long-known but enzymatically uncharacterized biosynthetic modification.\",\n      \"evidence\": \"cDNA cloning with recombinant expression in COS-7 cells, radiolabeled PAPS sulfotransferase assays, and disaccharide analysis\",\n      \"pmids\": [\"9988767\", \"9988768\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural information on the enzyme or its substrate-binding mode\", \"In vivo relevance of the anticoagulant HS product not yet tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Domain-swap chimeras demonstrated that the C-terminal sulfotransferase domain alone dictates 3-OST-1's unique 300-fold preference for generating antithrombin-binding sites over other 3-OST isoforms, resolving how isoform specificity is encoded.\",\n      \"evidence\": \"Domain-swap chimeras between 3-OST-1 and 3-OST-3A expressed in COS-7 and CHO cells with antithrombin-binding and HSV-1 entry readouts\",\n      \"pmids\": [\"11563988\", \"9988768\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific residues responsible for substrate discrimination not yet identified\", \"Upstream biosynthetic requirements not fully defined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Genetic epistasis in CHO cells revealed that 6-O-sulfotransferase-1 acts upstream of 3-OST-1 in the anticoagulant HS pathway, establishing the ordered biosynthetic logic.\",\n      \"evidence\": \"Chemical mutagenesis screen in 3-OST-1-transduced CHO cells with 6-OST-1 rescue and LC-MS disaccharide analysis\",\n      \"pmids\": [\"11551899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other 6-OST isoforms can substitute remains untested\", \"Full combinatorial sulfation code for the antithrombin-binding pentasaccharide not delineated\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Hs3st1 knockout mice resolved a central paradox: despite dramatic loss of anticoagulant HS, hemostasis was normal, demonstrating that bulk HSAT is dispensable for coagulation homeostasis and pointing to non-anticoagulant functions.\",\n      \"evidence\": \"Hs3st1−/− mice assessed by ferric chloride carotid injury, fibrin accumulation, thrombin-antithrombin complex measurements\",\n      \"pmids\": [\"12671048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cause of background-specific lethality and growth retardation unexplained\", \"Alternative in vivo roles of HSAT not yet explored\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The crystal structure of the 3-OST-1 ternary complex with PAP and a heptasaccharide substrate identified Arg268 as the key specificity-determining residue, providing an atomic-level explanation for isoform-specific substrate recognition.\",\n      \"evidence\": \"X-ray crystallography of the ternary complex with site-directed mutagenesis validation\",\n      \"pmids\": [\"22431632\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length structure including the transmembrane and stem regions\", \"How Golgi membrane context influences activity is unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Golgi-targeted 3-OST-1 produced functional antithrombin-binding sites while also upregulating other sulfation marks, revealing that 3-O-sulfation is integrated with coordinated HS biosynthetic regulation in the Golgi.\",\n      \"evidence\": \"Subcellular targeting constructs in CHO cells with flow cytometry, anti-factor Xa assay, and AMAC-LCMS disaccharide analysis\",\n      \"pmids\": [\"24247246\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of cross-regulation among HS biosynthetic enzymes not elucidated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Discovery that 3-O-sulfated HS produced by Hs3st1 enhances neuropilin-1 binding and modulates semaphorin-3a-induced growth cone collapse in neurons established a new non-anticoagulant signaling role for the 3-O-sulfate modification.\",\n      \"evidence\": \"Affinity chromatography, binding assays, neuronal growth cone collapse assays using Hs3st1−/− and Hs3st2−/− mouse neurons, endothelial sprouting assay\",\n      \"pmids\": [\"26731579\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo neuronal phenotype in Hs3st1−/− mice not systematically characterized\", \"Whether 3-O-sulfation alters semaphorin-neuropilin complex structure is unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Hs3st1 knockout mice lost antithrombin's anti-inflammatory activity during septic shock while retaining normal coagulation, definitively reassigning the primary in vivo function of HSAT from anticoagulation to anti-inflammation.\",\n      \"evidence\": \"LPS-induced septic shock in Hs3st1−/− mice with leukocyte adhesion, coronary arteriole dilation assays, and human SNP association study\",\n      \"pmids\": [\"28126521\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which HSAT-bound antithrombin suppresses inflammation at the molecular level not defined\", \"Whether the rs16881446 SNP is causal or a marker remains unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"3-O-sulfated HS produced by HS3ST1 was shown to enhance tau protein binding and cellular internalization, opening an entirely new disease-relevant axis for this modification in Alzheimer's pathology.\",\n      \"evidence\": \"HS microarray, SPR, Hs3st1−/− cell tau binding and uptake assays, NMR titration mapping tau-binding epitope\",\n      \"pmids\": [\"31692167\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo contribution to tau spread in brain not yet demonstrated\", \"Receptor or co-receptor mediating 3-O-S-dependent tau internalization not identified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of ZNF263 as a transcriptional repressor of HS3ST1 revealed an upstream regulatory mechanism controlling the abundance of 3-O-sulfated HS, with functional consequences for antithrombin binding and neuropilin-1 interaction.\",\n      \"evidence\": \"CRISPR knockout and siRNA knockdown of ZNF263 in cell lines and primary cells with qPCR, antithrombin binding, factor Xa inhibition, and neuropilin-1 binding assays\",\n      \"pmids\": [\"32277030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ZNF263 binding site on the HS3ST1 promoter not mapped\", \"Whether ZNF263 regulation is tissue-specific in vivo is unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"3-O-sulfated HS was found to be elevated sevenfold in Alzheimer's disease brains compared to controls, and all ApoE isoforms recognized this modification, linking HS3ST1 activity to two major AD risk pathways (tau and ApoE).\",\n      \"evidence\": \"LC-MS/MS of AD and control brain HS, synthetic 14-mer tau uptake inhibition, glycan microarray and SPR for ApoE binding, HS3ST1 KO cell validation\",\n      \"pmids\": [\"37235665\", \"37014788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HS3ST1 upregulation is a cause or consequence of AD pathology is unknown\", \"Therapeutic potential of 3-O-sulfated HS mimetics for blocking tau/ApoE binding untested in vivo\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"HS3ST1 inactivation in pancreatic cancer cells eliminated HSAT from basement membranes and increased metastasis, establishing that loss of 3-O-sulfated HS removes an antithrombin-dependent anti-metastatic barrier.\",\n      \"evidence\": \"HS3ST1 inactivation in PDAC cells, mouse metastasis model, antithrombin binding and thrombin generation assays, patient plasma HSAT measurement\",\n      \"pmids\": [\"40924474\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HSAT loss is a general feature of epithelial cancers beyond PDAC is unknown\", \"Mechanism linking HSAT loss to inflammatory phenotype in tumor cells not defined\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identification of E86 as the catalytic residue via dominant-negative E86Q mutagenesis provided the first active-site mechanism for 3-OST-1, complementing the structural understanding from the Arg268 specificity determinant.\",\n      \"evidence\": \"E86Q site-directed mutagenesis with LC-MS/MS enzymatic activity quantification and cell-based 3-O-sulfated HS measurement\",\n      \"pmids\": [\"41914643\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full catalytic mechanism (acid-base vs. direct transfer) not defined\", \"Whether E86Q dominant-negative approach works in vivo for functional studies not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include the structural basis for how 3-O-sulfated HS engages tau and ApoE at the cell surface, the identity of the internalization receptor/co-receptor for 3-O-S-dependent cargo uptake, whether HS3ST1 upregulation drives or follows AD pathology in vivo, and the full catalytic mechanism of 3-OST-1.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of 3-O-sulfated HS in complex with tau or ApoE receptor\", \"Internalization receptor for 3-O-S-dependent tau/ApoE uptake not identified\", \"Causal role of HS3ST1 in AD progression not demonstrated in vivo\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 4, 8, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 3, 4, 8, 9]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [6, 10, 20]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NRP1\", \"ZNF263\", \"HS6ST1\"],\n    \"other_free_text\": []\n  }\n}\n```"}